☆ 4.8 Article

Global burden of primary liver cancer in 2020 and predictions to 2040

JOURNAL OF HEPATOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Global, regional and national burden of primary liver cancer by subtype

Harriet Rumgay et al.

Summary: This study provides worldwide, regional, and national estimates of the incidence of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). The results show that HCC contributes the largest burden of liver cancer globally, with the highest rates in Eastern Asia, Northern Africa, and Southeastern Asia. iCCA rates are highest in Southeastern Asia, Eastern Asia, Northern Europe, the Caribbean and Central America, and Oceania.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Christian S. Alvarez et al.

Summary: This study examined the incidence and mortality rates of HCC in the USA between 1992 and 2018, finding that rates began to decline for most groups starting in 2015, although disparities continued to exist. The study highlighted that greater efforts are needed to reduce the burden of HCC among vulnerable groups such as non-Hispanic Black individuals and American Indians/Alaska Natives.

HEPATOLOGY (2022)

添加到收藏夹

Article Oncology

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019

Jonathan M. Kocarnik et al.

Summary: The global burden of cancer is substantial and growing, with differences in burden based on Sociodemographic Index (SDI). The largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles from 2010 to 2019.

JAMA ONCOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Epidemiology of Hepatocellular Carcinoma

Katherine A. McGlynn et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. While HBV and HCV remain important risk factors for HCC, efforts in vaccination and treatment are showing promise. However, the increasing prevalence of metabolic risk factors like obesity and diabetes, as well as other factors like excessive alcohol consumption, present ongoing challenges in the prevention of liver cancer.

HEPATOLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Comparison of liver cancer incidence and survival by subtypes across seven high-income countries

Mark J. Rutherford et al.

Summary: International comparison of liver cancer survival faces challenges due to differences in morphological verification standards and coding practices. This article presents comparisons of liver cancer survival across ICBP jurisdictions and highlights the poor survival rates in all countries. Australia has the highest survival rates, especially for morphologically verified tumors.

INTERNATIONAL JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study

Harriet Rumgay et al.

Summary: Alcohol use is causally linked to multiple cancers globally, with 741,300 new cancer cases attributable to alcohol consumption in 2020. Male accounted for the majority of alcohol-attributable cancer cases, with heavy drinking and risky drinking contributing most to the burden. Regional variations exist in the burden of alcohol-attributable cancers.

LANCET ONCOLOGY (2021)

添加到收藏夹

Article Oncology

International trends in hepatocellular carcinoma incidence, 1978-2012

Jessica L. Petrick et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012

Andrea A. Florio et al.

CANCER (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Global Burden of 5 Major Types of Gastrointestinal Cancer

Melina Arnold et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Oncology

Cancer registration in China and its role in cancer prevention and control

Wenqiang Wei et al.

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Christopher J. L. Murray et al.

LANCET (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30

David Tordrup et al.

LANCET GLOBAL HEALTH (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development

Justin R. Bailey et al.

GASTROENTEROLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity

Paulo S. Pinheiro et al.

JHEP REPORTS (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide

Delphine Maucort-Boulch et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012

Christopher Pham et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

添加到收藏夹

Article Medicine, General & Internal

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani et al.

LANCET (2018)

添加到收藏夹

Article Oncology

Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012

Christopher Pham et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon et al.

GASTROENTEROLOGY (2017)

添加到收藏夹

Article Infectious Diseases

Requirements for global elimination of hepatitis B: a modelling study

Shevanthi Nayagam et al.

LANCET INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Oncology

Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients

Jannemarie de Ridder et al.

ONCOTARGET (2016)

添加到收藏夹

Article Medicine, General & Internal

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

Aparna Schweitzer et al.

LANCET (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality

Matthew E. Cramp et al.

BMC GASTROENTEROLOGY (2014)

添加到收藏夹

Letter Medicine, General & Internal

Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan

Chun-Ju Chiang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Elimination of Hepatocellular Carcinoma and Acute Hepatitis B in Children 25 Years After a Hepatitis B Newborn and Catch-Up Immunization Program

Brian J. McMahon et al.

HEPATOLOGY (2011)

添加到收藏夹

Article Public, Environmental & Occupational Health

Cancer Incidence Among Canadian Immigrants, 1980-1998: Results from a National Cohort Study

Sarah McDermott et al.

JOURNAL OF IMMIGRANT AND MINORITY HEALTH (2011)

添加到收藏夹

Article Environmental Sciences

Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment

Yan Liu et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2010)

添加到收藏夹

Article Oncology

Cancer risk diversity in non-western migrants to Europe: An overview of the literature

Melina Arnold et al.

EUROPEAN JOURNAL OF CANCER (2010)

添加到收藏夹

Review Oncology

Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection

Shu-Chun Chuang et al.

CANCER LETTERS (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.